jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Mar. 30, 2019

Mar. 30, 2026

jRCTs051180229

ALS biomarker research using patient clinical samples

ALS biomarker research

Inoue Haruhisa

Kyoto University

53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

+81-75-366-7360

prj-als_bosutinib@cira.kyoto-u.ac.jp

Inoue Haruhisa

Kyoto University

53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

+81-75-366-7360

prj-als_bosutinib@cira.kyoto-u.ac.jp

Recruiting

Mar. 31, 2019

April. 19, 2019
49

Interventional

non-randomized controlled trial

open(masking not used)

historical control

parallel assignment

basic science

Those who agree to attend the current clinical study among ALS patients joining an accompanying clinical trial "Phase 1/2 Dose Escalation Study of Bostinib in Patients with Amyotrophic Lateral Sclerosis (ALS)"

N/A

20age old over
75age old under

Both

amyotrophic lateral sclerosis (ALS)

collection of cerebrospinal fluid

ALS

Alteration of blood biomerkers including SOD1, TDP-43, Src, c-Abl, etc.
Alteration of CSF biomerkers including neurofilament L, phosphorylated neurofilament H, SOD1, TDP-43, etc.
Alteration of urine biomerkers including p75, etc.
Plasma concentration of bosutinib (through value)
CSF concentration of bosutinib (through value)
Evaluation of biomerkers using iPS cells

N/A

Japan Agency for Medical Research and Development
Kyoto University Certified Review Board
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN, Kyoto

+81-75-753-4680

ethcom@kuhp.kyoto-u.ac.jp
Approval

Mar. 04, 2019

No

none

History of Changes

No Publication date
15 Mar. 30, 2026 (this page) Changes
14 Mar. 31, 2025 Detail Changes
13 Nov. 08, 2024 Detail Changes
12 May. 15, 2024 Detail Changes
11 Jan. 26, 2024 Detail Changes
10 April. 26, 2023 Detail Changes
9 Nov. 29, 2022 Detail Changes
8 Oct. 19, 2022 Detail Changes
7 Mar. 30, 2022 Detail Changes
6 June. 09, 2021 Detail Changes
5 Feb. 08, 2021 Detail Changes
4 Aug. 06, 2019 Detail Changes
3 July. 22, 2019 Detail Changes
2 April. 22, 2019 Detail Changes
1 Mar. 30, 2019 Detail